Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
10.74
+0.37 (3.57%)
At close: Aug 3, 2026, 4:00 PM EDT
10.74
0.00 (0.00%)
After-hours: Aug 3, 2026, 4:20 PM EDT

Korro Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.846.392.27--14.07
Revenue Growth
-20.31%181.46%----61.96%
Gross Profit
3.846.392.27--14.07
Operating Income
-117.27-121.86-91.91-84.53-59-84.03
Net Income
-113.5-117.26-83.58-81.17-58.03-84.69
Earnings Per Share
-11.67-12.48-9.37-53.08-227.42-4.94
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
113.9775.16126.1166.1555.25130.71
Total Debt
42.8943.4944.7733.213.1345.6
Net Cash (Debt)
71.0931.6781.33132.9452.1285.11
Net Cash Growth
1.89%-61.06%-38.82%155.08%-38.76%-51.18%
Net Cash Per Share
7.143.379.1286.9380.79131.94

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-70.18-78.56-60.07-67.28-53.65-76.06
Capital Expenditures
-0.42-0.52-17.9-7.84-5.21-2.91
Free Cash Flow
-70.6-79.08-77.98-75.12-58.86-78.97
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%--100.00%
Operating Margin
-3052.34%-1906.37%-4047.12%---597.32%
Pretax Margin
-2935.09%-1824.52%-3674.15%---601.87%
Profit Margin
-2954.14%-1834.48%-3680.36%---601.98%
FCF Margin
-1837.66%-1237.16%-3433.55%---561.37%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
40.4311.80157.20--12.62